DPHARMA-7148

DUOPHARMA BIOTECH BERHAD

Last Price: 1.71

TTM Dividend Yield : 3.8%

Coming Quarter Report: ~ 2022-02-22

Yahoo Google Bursa Web TradingView

Sector: Pharmaceuticals

No record found

**Do feedback to us if you see any error on the data

**Data before 2015 may not be accurate

**Dividend Yield calculated base on the last price of the year

DPHARMA Dividend Yield Trend

DPHARMA Quarter DY Yield

DPHARMA Annual DY Yield

DPHARMA Quarter Report History

DPHARMA Quarter Profit Trend

DPHARMA Annual Profit Trend

Cash Flow

In financial accounting, operating cash flow (OCF), cash flow provided by operations, cash flow from operating activities (CFO) or free cash flow from operations (FCFO), refers to the amount of cash a company generates from the  revenues it brings in, excluding  costs associated with long – term  investment  on capital items or investment in securities.(From Wiki)

DPHARMA Annual Cash Flow

 

ROE & Payout Ratio

Return on equity (ROE) is a measure of financial performance calculated by dividing net income by shareholders’ equity. Because shareholders’ equity is equal to a company’s assets minus its debt, ROE is considered the return on net assets. ROE is considered a measure of the profitability of a corporation in relation to stockholders’ equity. (From Investopedia)

The payout ratio is a financial metric showing the proportion of earnings a company pays its shareholders in the form of dividends, expressed as a percentage of the company’s total earnings. On some occasions, the payout ratio refers to the dividends paid out as a percentage of a company’s cash flow. The payout ratio is also known as the dividend payout ratio. (From Investopedia)

DPHARMA Annual ROE & Payout Ratio



0 Comments

  1. Duopharma Biotech Bhd is an investment holding company engaged in manufacturing pharmaceuticals. It develops, manufactures and markets generic and over-the-counter pharmaceutical products. The operating segment of the company is manufacturing and distribution of pharmaceutical products. The principal activities of its subsidiary are to carry out business as a manufacturer, distributor, importer and exporter of pharmaceutical products and medicines.

    Reply

Leave a Reply

Your email address will not be published. Required fields are marked *